(3) Promptly reporting to the Race Secretary and the Department Veterinarian if a posterior digital neurectomy (heel nerving) is performed on a horse in his or her care and ensuring that this fact is designated on its certificate of registration; (4) Promptly reporting to the Race Secretary the name of a mare in his or her care that has been bred and is entered to race; (5) Promptly notifying the Department Veterinarian of a reportable disease or communicable illness in a in his or her care; (6) Promptly reporting the serious injury or death of a horse in his or her care at a location under the jurisdiction of the Commission to the State Steward and the Department Veterinarian and ensuring compliance with Chapter 1, section 20 of Commission rules; (7) Promptly notifying the Stewards and the Department Veterinarian if the trainer has knowledge or reason to believe that there has been an administration to a horse of a drug, medication, or other substance prohibited by Commission rules or has knowledge or reason to believe that a prohibited practice has occurred as set forth in this chapter; (8) Ensuring the fitness of every horse in his or her care to perform a creditable race at the distance entered; and, (9) Ensuring the horse’s presence in the paddock at least one hour prior to post time of the race in which the horse is to compete. F. The trainer is responsible for, and is the absolute ensurer of the condition of, the horse that the trainer enters regardless of the acts of other parties. Section 2. Prohibited Substances 1. No person may permit, authorize, or conspire to permit or authorize, the administration of a substance to a horse which results in the presence of a prohibited substance, as described in this subsection, in a horse that participates in a race or that is programmed to participate in a race. 2. Except when otherwise identified as a Permitted Substance under Section 4 of this chapter, a substance is a prohibited substance if it appears on the Uniform Classification Guidelines for Foreign Substances And Recommended Penalties Model Rule. January, 2018 (V.13.4) published by the Association of Racing Commissioners International, unless the substance is permitted substance as described in Section 4 of this chapter and is present below the Maximum Allowable Concentration established by Commission rule in this chapter.
Section 4. Permitted Substances 1. Therapeutic Medications Veterinarians may administer the following medications to participating horses provided that, on any day for the horse is entered to race, the urine and/or blood concentrations are below the Maximum Allowable Concentrations listed in the table below. Administration of medications not described in this section is prohibited. Therapeutic Medication Maximum Allowable Concentration Acepromazine 10 nanograms per milliliter as promazine sulfoxide (HEPS) in urine Albuterol 1 nanogram per milliliter of urine Betamethasone 10 picograms per milliliter of plasma or serum Butorphanol 300 nanograms of total butorphanol in urine or 2 nanograms of free butorphanol per milliliter of plasma or serum Cetirzine 6 nanograms per milliliter of plasma or serum Cimetidine 400 nanograms per milliliters of plasma or serum Clenbuterol 140 picograms per milliliter or urine or Level of Detection in plasma or serum Dantrolene 100 picograms per milliliter of in plasma or serum Detomidine 2 nanograms per milliliter of carboxydetomidine in urine or 1 nanogram per milliliter in blood Dexamethasone 5 picograms per milliliter of plasma or serum Diclofenac 5 nanograms per milliliter of plasma or serum Dimethyl sulfoxide (DMSO) 10 micrograms per milliliter of plasma or serum Firocoxib 20 nanograms per milliliter of plasma or serum Flunixin 20 nanograms per milliliter of plasma or serum Furosemide 100 nanograms per milliliter of plasma or serum Glycopyrrolate 3 picograms per milliliter of plasma or serum Guaifenesin 12 nanoper milliliter of plasma or serum Isoflupredone 100 nanograms permilliliter of plasma or serum Ketoprofen 2 nanograms per milliliter of plasma or Lidocaine 20 picograms per milliliter of total in plasma or serum
may not prevent a violation of this section. Adherence to those guidelines does not constitute a defense. C. The presence of more than one NSAID may constitute a NSAID stacking violation consistent with the following restrictions: (1) A Class 1 NSAID Stacking Violation (Penalty Class B) occurs when: (a) Two non-steroidal anti-inflammatory are found at individual levels determined to exceed the following restrictions: (i) Diclofenac – 5 nanograms per milliliter of plasma or serum; (ii) Firocoxib - 20 nanograms per milliliter of plasma or (iii) Flunixin – 20 nanograms per milliliter of plasma or serum; (iv) Ketoprofen – 2 nanograms per milliliter of plasma or (v) Phenylbutazone – 5 micrograms per milliliter of plasma or serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (b) Three or more non-steroidal anti-inflammatory drugs are found at individual levels determined to exceed the following restrictions: (i) Diclofenac – 5 nanograms per milliliter of plasma or serum; (ii) Firocoxib - 20 nanograms per milliliter of plasma or serum; (iii) Flunixin – 3 nanograms per milliliter of plasma or (iv) Ketoprofen – 1 nanograms per milliliter of plasma or serum; (v) Phenylbutazone – 0.5 micrograms per milliliter of plasma or serum; or (vi) all other non-steroidal anti-inflammatory drugs – laboratory concentration of detection. (2) A Class 2 NSAID Stacking Violation (Penalty Class C) occurs when: (a) Any one substance in Subsection (1)(a) above is found in excess of the restrictions contained therein in combination with any one of the following substances at levels below the restrictions so noted but in excess of the following levels: